Literature DB >> 4716782

Preliminary trial of aminoglutethimide in breast cancer.

C T Griffiths, T C Hall, Z Saba, J J Barlow, H B Nevinny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4716782     DOI： 10.1002/1097-0142(197307)32:1<31::aid-cncr2820320104>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  12 in total

Review 1.  Anticancer drug discovery and pharmaceutical chemistry: a history.

Authors:  Miguel F Braña; Ana Sánchez-Migallón
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

Review 2.  Aromatase inhibitors: past, present and future in breast cancer therapy.

Authors:  Udayan Dutta; Kartikeya Pant
Journal:  Med Oncol       Date:  2007-11-01       Impact factor: 3.064

3.  Cancer of the breast: forward look in the 1970s. Endocrine therapy-the future.

Authors:  J Hayward
Journal:  Proc R Soc Med       Date:  1974-04

4.  Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.

Authors:  S A Wells; R J Santen; A Lipton; D E Haagensen; E J Ruby; H Harvey; W G Dilley
Journal:  Ann Surg       Date:  1978-05       Impact factor: 12.969

Review 5.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

6.  Update in cancer chemotherapy: general considerations and breast cancer, Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-08       Impact factor: 1.798

7.  The absolute configuration of the enantiomers of glutethimide and aminoglutethimide.

Authors:  N Finch; R Dziemian; J Cohen; B G Steinetz
Journal:  Experientia       Date:  1975-09-15

Review 8.  Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors:  R J Santen
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

Review 9.  First generation aromatase inhibitors--aminoglutethimide and testololactone.

Authors:  G Cocconi
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 10.  Aromatase inhibitors in malignant diseases of aging.

Authors:  D C Johannessen; P E Lønning
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.